MEDVi Review

MEDVi in brief

MEDVi is a cash-pay online clinic built around compounded semaglutide. The first month costs $99, refills cost $199 a month, and the medication, the clinician review and shipping sit inside that figure. It also arranges brand Wegovy and Zepbound, but for those it charges a $99 membership and leaves the drug price unpublished.

Two facts frame everything else. You pay before a clinician looks at your case, and the FDA sent MEDVi a warning letter in February 2026 over how it labeled and described its compounded drugs. Neither is hidden on MEDVi's own pages, and both belong in your decision.

What you get for the money

MEDVi's program page lists what the monthly price covers. The list is longer than most in this segment, though one item carries a condition.

• The prescription and the medication, shipped to your door at no extra charge
• A clinician review and a personalized plan, plus what MEDVi calls a metabolic report
• Unlimited messaging and 24/7 support, through a patient portal that also tracks progress
• Dietitian visits and care coaching, billed as free, with fine print that ties them to insurance and copay eligibility checked at the visit

The coaching team is described as certified medical assistants and registered dietitians. Treat the dietitian visits as a possible extra rather than a sure thing until the visit itself confirms the terms.

Pricing by product, and what changes at refill

MEDVi publishes four products. Only the compounded ones have a complete price on the page.

• Compounded semaglutide injection, one shot a week: $99 for the first month, then refills locked in at $199 a month
• Compounded GLP-1 tablet, one dissolvable tablet a day: from $249 a month, with no intro discount shown
• Wegovy pill or Wegovy injection: a $99 membership plus the medication cost, which MEDVi does not publish
• Zepbound injection: the same $99 membership plus an unpublished medication cost; MEDVi notes that availability is subject to change

The jump that matters is month two. The injection price doubles from the first month to the refill rate, so budget on $199, not $99. MEDVi says the refill price is locked in. It does not publish a dose-by-dose table, so ask before checkout whether a higher maintenance dose changes the bill. The daily tablet has far thinner evidence than the weekly shot: the approved semaglutide tablet absorbs only about 1% to 2% of its dose, and no human absorption study of sublingual semaglutide drops has been published.

There is no compounded tirzepatide on the menu. The only tirzepatide path is brand Zepbound through the membership, and the true monthly cost of that path is unknown until you are inside the program. Brand Wegovy works the same way, though the manufacturer's own prices are public: what the Wegovy pill costs by dose gives you a figure to hold MEDVi's quote against.

How sign-up works

The intake opens with a state menu and then asks for height, weight and goal weight. From there you answer the medical questions and pay for the first month. MEDVi's own disclosure says an OpenLoop Health clinician meets with you after checkout to decide whether you qualify, and that the clinician keeps the decision to prescribe.

• Step 1: a short online assessment that screens out people who do not meet the criteria
• Step 2: checkout, which starts your membership
• Step 3: a clinician review, live or by message, after payment
• Step 4: if approved, the pharmacy ships the medication to your door

MEDVi promises free, expedited delivery but gives no shipping time in days. If timing matters, ask support for a current estimate before you pay.

Pharmacies and clinicians

MEDVi names three partner pharmacies, each with a street address: Triad Rx (Alabama), RedRock Pharmacy (Utah) and Beaker Pharmacy & Compounding (Texas). It does not say which one fills a given order. It states plainly that it does not make the medication and that what arrives may look different from the pictures on its site.

Medical care comes from CareGLP Affiliated P.C.s and the OpenLoop Health network. MEDVi itself is the brand and the storefront, run by MEDVi, LLC from an office in Newark, Delaware.

Where MEDVi is available

MEDVi publishes no separate state list. Its sign-up form offers all 50 states and Washington, D.C., while its terms say service covers certain states and point you to customer service for the current list. A menu entry is not a promise of service, so confirm your state before you pay.

Insurance, HSA and FSA

Every MEDVi prescription is cash-pay. Its terms say its clinicians are not contracted with any insurance plan, Medicare and Medicaid included. MEDVi says insurance may reimburse you for the brand-name drugs, which means you pay first and file the claim yourself. The sales page calls the program HSA/FSA approved.

Cancellation and refunds

Cancellation is open whenever you want it, through email or the portal chat. Give three full days of notice before the next billing date; a later request means one more cycle is charged. Compare that, and the refund rules below, with other GLP-1 sellers' cancellation and refund policies before you sign up.

• Full refund if a clinician disqualifies you for a medical reason
• Full refund inside your first three days, provided no service has started
• No refund for the month you cancel in, or any earlier month, on a monthly plan
• Partial refund on plans billed two or more months at a time, for months with no medication shipped

The FDA warning letter

MEDVi, LLC received an FDA warning letter dated February 20, 2026. The agency said labels pictured on MEDVi's site implied that MEDVi compounds the drugs itself, and that claims of the same active ingredient as the brand drugs implied FDA approval. MEDVi's current pages say compounded medications are not FDA approved and that MEDVi does not produce them. Our FDA warning letter tracker explains what these letters do and do not mean. The subject is a common one: most of the FDA's GLP-1 warning letters concern what sellers said rather than what pharmacies made.

MEDVi and ElixaMD

ElixaMD runs on the same Newark street address, the same terms wording, the same clinical groups and the same three pharmacies. Its compounded semaglutide carries the same first-month and refill prices. The two are separate LLCs, and MEDVi is the larger storefront: it adds the daily tablet that ElixaMD does not list.

What MEDVi does not disclose

• The medication price for brand Wegovy and Zepbound
• Which of its three pharmacies fills your order
• A state list in its terms; the sign-up menu is the only list it shows
• A shipping time in days
• Whether the refill price holds at every dose

Its headline results, an 18% average loss and 93% keeping the weight off, are self-reported by its own customers, and MEDVi says some site content may be AI-generated and that people in its ads may be actors.

Who it suits, and who should look elsewhere

MEDVi fits a cash payer who wants compounded semaglutide, likes a cheap first month, and wants the choice of a daily tablet instead of a weekly shot. Named pharmacies and round-the-clock messaging help.

Look elsewhere if you want compounded tirzepatide, a published brand-drug price, insurance billing, or a refund after the first few days. The February 2026 warning letter is also a reason to prefer a seller with a cleaner history if you have the option. Our scoring methodology shows how these factors are weighed.

Bottom line

MEDVi is a straightforward compounded semaglutide program: $99 to start, $199 a month after, medication and shipping included, three named pharmacies. The trade is paying before a clinician sees you, a strict refund policy, an unpublished brand-drug price and a recent FDA letter. Go in on the refill price, not the first-month one.